Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2020-06-30, filed 2020-08-14, with 80 holding rows worth $5,416,834,000.

Accession
0001104659-20-095551
Filed
2020-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2020

A holdings report, 80 entries on the cover page, a total value of $5,416,834,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,416,834,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
FATE THERAPEUTICS INC31189P102COM12,629,737$433,326,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM24,944,695$376,166,000thousands by filing date
DECIPHERA PHARMACEUTICALS IN24344T101COM4,978,941$297,342,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK5,525,870$258,666,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR1,034,868$233,083,000thousands by filing date
IGM BIOSCIENCES INC449585108COM3,144,000$229,512,000thousands by filing date
BIONTECH SE SPONSORED ADS09075V102ADR3,069,164$204,836,000thousands by filing date
ALLAKOS INC01671P100COM2,619,080$188,207,000thousands by filing date
PRINCIPIA BIOPHARMA INC74257L108COM2,712,388$162,174,000thousands by filing date
MOMENTA PHARMACEUTICALS INC60877T100COM4,705,308$156,546,000thousands by filing date
EPIZYME INC29428V104COM8,485,605$136,279,000thousands by filing date
IMMUNOMEDICS INC452907108COM3,489,900$123,682,000thousands by filing date
PLIANT THERAPEUTICS INC729139105COM3,410,657$110,710,000thousands by filing date
1LIFE HEALTHCARE INC68269G107COM3,010,684$109,348,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock6,843,370$99,708,000thousands by filing date
BEAM THERAPEUTICS INC07373V105COM3,356,958$93,995,000thousands by filing date
Cigna Corporation125523100COM486,100$91,217,000thousands by filing date
APREA THERAPEUTICS INC03836J102COM2,268,718$87,981,000thousands by filing date
REGENXBIO INC75901B107COM2,236,766$82,380,000thousands by filing date
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK1,661,205$79,771,000thousands by filing date
REPLIMUNE GROUP INC76029N106COMMON STOCK3,104,193$77,139,000thousands by filing date
REPARE THERAPEUTICS INC760273102COM2,386,174$74,019,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM4,903,400$72,129,000thousands by filing date
NEOLEUKIN THERAPEUTICS INC64049K104COM4,041,211$67,084,000thousands by filing date
HILL ROM HLDGS INC431475102COM585,000$64,221,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR1,225,500$62,562,000thousands by filing date
STOKE THERAPEUTICS INC86150R107COM2,502,306$59,630,000thousands by filing date
NEVRO CORP64157F103COM497,764$59,468,000thousands by filing date
KRYSTAL BIOTECH INC COM501147102Stock1,409,745$58,392,000thousands by filing date
TRICIDA INC89610F101COM2,119,000$58,230,000thousands by filing date
UNIQURE NVN90064101SHS1,247,135$56,196,000thousands by filing date
IMMUNOGEN INC45253H101COMMON STOCK12,006,979$55,232,000thousands by filing date
CRYOPORT INC COM PAR $0.001229050307Stock1,817,663$54,984,000thousands by filing date
SCHOLAR ROCK HLDG CORP80706P103COM2,875,889$52,370,000thousands by filing date
PPD INC69355F102COM1,933,473$51,817,000thousands by filing date
AMEDISYS INC023436108COM226,165$44,903,000thousands by filing date
DYNAVAX TECHNOLOGIES CORP268158201COM NEW5,062,100$44,901,000thousands by filing date
BIOGEN INC COM09062X103Stock162,300$43,423,000thousands by filing date
AXONICS INC05465P101COM1,192,100$41,855,000thousands by filing date
Merck & Co.,Inc.58933Y105COM524,300$40,544,000thousands by filing date
DEXCOM INC COM252131107Stock97,300$39,445,000thousands by filing date
NOVARTIS AG SPONSORED ADR66987V109ADR439,800$38,412,000thousands by filing date
ICU MED INC44930G107COM201,400$37,120,000thousands by filing date
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share1,057,393$35,835,000thousands by filing date
Boston Scientific Corporation101137107COM897,355$31,506,000thousands by filing date
UnitedHealth Group Inc91324P102COM103,900$30,645,000thousands by filing date
CATALENT INC USD 0.01148806102COM413,100$30,280,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK917,907$29,860,000thousands by filing date
EIDOS THERAPEUTICS INC.28249H104Common Stock593,842$28,308,000thousands by filing date
ZYMEWORKS INC98985W102COM783,500$28,261,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM279,336$27,177,000thousands by filing date
TCR2 THERAPEUTICS INC87808K106COM1,765,188$27,113,000thousands by filing date
ODONATE THERAPEUTICS INC676079106COM633,038$26,803,000thousands by filing date
TWIST BIOSCIENCE CORP90184D100COM589,300$26,695,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW2,000,000$26,000,000thousands by filing date
ARDELYX INC039697107COM3,514,100$24,318,000thousands by filing date
GUARDANT HEALTH INC COM40131M109Stock297,619$24,146,000thousands by filing date
HOOKIPA PHARMA INC43906K100COM1,860,610$21,620,000thousands by filing date
ATRECA INC04965G109COM992,068$21,111,000thousands by filing date
GRITSTONE BIO INC39868T105COM3,064,994$20,352,000thousands by filing date
CABALETTA BIO INC12674W109COMMON STOCK1,425,896$15,884,000thousands by filing date
IMMUNOVANT INC45258J102COM600,000$14,610,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK3,103,327$13,841,000thousands by filing date
INVITAE CORP46185L103COM431,100$13,058,000thousands by filing date
SELECTQUOTE INC816307300COM496,872$12,586,000thousands by filing date
ITAMAR MED LTD SPONSORED ADS465437101ADR625,000$11,625,000thousands by filing date
AKERO THERAPEUTICS INC00973Y108COM392,152$9,772,000thousands by filing date
ROYALTY PHARMA PLCG7709Q104SHS CLASS A200,000$9,710,000thousands by filing date
BRISTOL-MYERS SQUIBB CO110122157RIGHT 99/99/99992,467,000$8,832,000thousands by filing date
PROFOUND MED CORP74319B502COM NEW400,000$6,776,000thousands by filing date
AYALA PHARMACEUTICALS INC05465V108COM666,666$6,687,000thousands by filing date
XERIS PHARMACEUTICALS INC98422L107COM2,397,441$6,377,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM1,674,447$5,844,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock415,155$4,322,000thousands by filing date
BURNING ROCK BIOTECH LTD12233L107SPONSORED ADS133,931$3,617,000thousands by filing date
SYROS PHARMACEUTICALS INC87184Q107COM212,291$2,263,000thousands by filing date
VAPOTHERM INC922107107COM25,000$1,025,000thousands by filing date
OVID THERAPEUTICS INC690469101COMMON STOCK121,950$899,000thousands by filing date
ENDOLOGIX INC29266S304COM NEW78,755$63,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock10,229$8,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-20-095551this filing2020-08-14acceptance time not in the bulk data set